on the "SEC Filings" section of our website atwww.verupharma.com/investors. Contact: Kevin Gilbert EFTA00857651 This messa ,e was distributed by Nasda 's GlobeNewswire. USA , www.nasdaq.com) On behalf of Vern Healthcare Chicago. IL 6060I US This message was sent to If you wish to no longer rec